Program
Pregabalin
Also written as “pregabalin”, “pregabalin (Lyrica)” and “Pregabalin ER”.
Its studies are mostly in Neuralgia · Fibromyalgia · Diabetic Neuropathies · Epilepsies, Partial · Neuralgia, Postherpetic, led by 18 companies.
Drug pagePregabalin: every studyMany companies study it; this page follows only the 142 they lead. All 390 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Viatrisits history only | 940 open or running | phase 4since Aug 31, 2005 | Aug 30, 2005 | none ahead |
| Pfizerits history only | 180 open or running | phase 4since Apr 16, 2012 | Aug 30, 2005 | none ahead |
| Yuhanits history only | 80 open or running | phase 4since Apr 13, 2021 | Aug 17, 2011 | none ahead |
| GL Pharm Techits history only | 40 open or running | phase 1since Jul 4, 2012 | Jul 4, 2012 | none ahead |
| Laboratorios Silanes S.A. de C.V.its history only | 30 open or running | phase 3since Apr 4, 2022 | Apr 4, 2022 | none ahead |
| Merckits history only | 20 open or running | phase 1since Dec 7, 2007 | Dec 7, 2007 | none ahead |
| Nevakarits history only | 20 open or running | phase 2since Jul 27, 2020 | Jan 29, 2020 | none ahead |
| Analgesic Solutionsits history only | 10 open or running | phase 4since Dec 13, 2012 | Dec 13, 2012 | none ahead |
| Depomedits history only | 10 open or running | phase 4since Jun 5, 2017 | Jun 5, 2017 | none ahead |
| Dexa Medica Groupits history only | 10 open or running | no phasesince Sep 4, 2014 | Sep 4, 2014 | none ahead |
| Egymedicalpediaits history only | 10 open or running | early phase 1since Apr 8, 2023 | Apr 8, 2023 | none ahead |
| Hypera Pharmaits history only | 11 open or running | phase 3since Jun 18, 2026 | Jun 18, 2026 | Jun 1, 2027phase 3 · NCT07712913 |
| Jiangsu HengRui Medicineits history only | 10 open or running | phase 3since Jul 8, 2015 | Jul 8, 2015 | none ahead |
| KRKAits history only | 10 open or running | phase 4since Jan 24, 2020 | Jan 24, 2020 | none ahead |
| Latigo Biotherapeuticsits history only | 10 open or running | early phase 1since Sep 13, 2024 | Sep 13, 2024 | none ahead |
| Unimed Pharmaceuticalsits history only | 10 open or running | phase 1since Mar 3, 2013 | Mar 3, 2013 | none ahead |
| Yung Shin Pharm. Ind.its history only | 10 open or running | phase 4since Oct 8, 2018 | Oct 8, 2018 | none ahead |
| Yungjin Pharm.its history only | 10 open or running | phase 1since Aug 22, 2017 | Aug 22, 2017 | none ahead |
Also a collaborator on its studies: Nevakar Injectables, Boehringer Ingelheim and Astellas Pharma.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.
Before these, 46 studies since Nov 23, 2009.
- Oct 8, 2018Yung Shin Pharm. Ind.’s first study: phase 4 study in FibromyalgiaNew to Yung Shin Pharm. Ind.Yung Shin Pharm. Ind. · NCT03712475 · 28 enrolled · Taiwan
- Jun 9, 2019Named pregabalinINNProposed as its International Nonproprietary Name in WHO's List 121
- Jan 24, 2020KRKA’s first study: phase 4 study in Painful Diabetic Peripheral NeuropathyNew to KRKAKRKA · NCT04246619 · 254 enrolled · Croatia, North Macedonia, Poland and more
- Jan 29, 2020Nevakar’s first study: phase 1 study in Pain, PostoperativeNew to NevakarNevakar · NCT04265456 · 63 enrolled · United States
- Jul 27, 2020Phase 2 study in Pain, PostoperativeNevakar · NCT04495283 · 87 enrolled · United States
- Apr 13, 2021Phase 4 study in Diabetic Peripheral NeuropathyYuhan · NCT04846673 · 151 enrolled · Korea, Republic of
- Jul 27, 2021Phase 1 study in Healthy VolunteerYuhan · NCT05012436 · 16 enrolled · Korea, Republic of
- Sep 13, 2021Phase 4 study in Abuse PotentialViatris · NCT05053126 · 60 enrolled · United States
- Apr 4, 2022Laboratorios Silanes S.A. de C.V.’s first study: phase 3 study in NeuralgiaNew to Laboratorios Silanes S.A. de C.V.Laboratorios Silanes S.A. de C.V. · NCT05324059 · 110 enrolled · Mexico
- May 19, 2022Phase 1 study in Acute PainLaboratorios Silanes S.A. de C.V. · NCT05389150 · 30 enrolled · Mexico
- Nov 14, 2022Phase 4 study in NeuralgiaYuhan · NCT05624853 · 130 enrolled · Korea, Republic of
- Apr 8, 2023Egymedicalpedia’s first study: early phase 1 study in Endoscopic Sinus SurgeryNew to EgymedicalpediaEgymedicalpedia · NCT05829148 · 120 enrolled · Egypt
- Jun 26, 2024Phase 3 study in Low Back PainLaboratorios Silanes S.A. de C.V. · NCT06516094 · 192 enrolled · Mexico
- Sep 13, 2024Latigo Biotherapeutics’ first study: early phase 1 study in Pain DetectionNew to Latigo BiotherapeuticsLatigo Biotherapeutics · NCT06600607 · 20 enrolled · New Zealand
- Jun 18, 2026Hypera Pharma’s first study: phase 3 study in Diabetic NeuropathiesNew to Hypera PharmaHypera Pharma · NCT07712913 · 348 planned · Brazil
Ahead
- Jun 1, 2027Primary completion: phase 3 study in Diabetic NeuropathiesHypera Pharma · NCT07712913
TargetBeta
“Voltage-gated calcium channel modulator”ChEMBL 37, by rule
Other programs on the same 26 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Gabapentinrule | Viatris | phase 4 | 49 |
Studies
The newest 60 of 142 led by companies developing it. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07712913Diabetic Neuropathies · Brazil | 3 | Recruiting | Hypera Pharma | Jun 1, 2027 | 348 |
| NCT06600607Pain Detection · New Zealand | Early 1 | Completed | Latigo Biotherapeutics | Oct 27, 2024 | 20 |
| NCT06516094Low Back Pain · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Jan 1, 2025 | 192 |
| NCT05829148Endoscopic Sinus Surgery · Egypt | Early 1 | UNKNOWN | Egymedicalpedia | Nov 1, 2024 | 120 |
| NCT05624853Neuralgia · Korea, Republic of | 4 | Completed | Yuhan | Dec 20, 2022 | 130 |
| NCT05389150Acute Pain · Mexico | 1 | Completed | Laboratorios Silanes S.A. de C.V. | Feb 5, 2019 | 30 |
| NCT05324059Neuralgia · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Apr 18, 2023 | 110 |
| NCT05053126Abuse Potential · United States | 4 | Completed | Viatris | Apr 1, 2022 | 60 |
| NCT05012436Healthy Volunteer · Korea, Republic of | 1 | Completed | Yuhan | May 10, 2022 | 16 |
| NCT04846673Diabetic Peripheral Neuropathy · Korea, Republic of | 4 | Completed | Yuhan | Nov 30, 2022 | 151 |
| NCT04495283Pain, Postoperative · United States | 2 | Completed | Nevakar | Nov 12, 2020 | 87 |
| NCT04265456Pain, Postoperative · United States | 1 | Completed | Nevakar | Jun 15, 2020 | 63 |
| NCT04246619Painful Diabetic Peripheral Neuropathy · Croatia, North Macedonia, Poland and more | 4 | Terminated | KRKA | Dec 21, 2021 | 254 |
| NCT03712475Fibromyalgia · Taiwan | 4 | Completed | Yung Shin Pharm. Ind. | Sep 16, 2018 | 28 |
| NCT03261427Healthy · Korea, Republic of | 1 | Completed | Yungjin Pharm. | Oct 11, 2017 | 17 |
| NCT03179345Healthy | 4 | Completed | Depomed | Nov 20, 2015 | 32 |
| NCT03191136Peripheral Neuropathic Pain · Korea, Republic of | 1 | Completed | Yuhan | Jun 27, 2017 | 24 |
| NCT02985216Peripheral Neuropathic Pain · Korea, Republic of | 3 | Completed | Yuhan | Apr 27, 2018 | 371 |
| NCT02783183Peripheral Nueropathy Pain | 1 | Completed | Yuhan | Aug 2016 | 32 |
| NCT02783638Peripheral Neuropathy Pain · Korea, Republic of | 1 | Completed | Yuhan | Apr 2016 | 64 |
| NCT02725112Healthy · United States | 1 | Completed | Viatris | May 22, 2016 | 25 |
| NCT02868801Neuralgia, Postherpetic · China | 3 | UNKNOWN | Jiangsu HengRui Medicine | Jun 2017 | 280 |
| NCT02327000Healthy | 1 | Completed | GL Pharm Tech | Oct 2014 | 40 |
| NCT02326987Healthy | 1 | Completed | GL Pharm Tech | Nov 2013 | 30 |
| NCT02233777Healthy · Indonesia | – | Completed | Dexa Medica Group | Jun 2014 | 20 |
| NCT02215252Diabetic Neuropathies · United States | 2 | Completed | Pfizer | Jul 15, 2015 | 141 |
| NCT02072824Epilepsy · United States, Belarus, Belgium and more | 3 | Completed | Viatris | Mar 13, 2018 | 175 |
| NCT01838044Chronic Low Back Pain With a Neuropathic Component · Brazil, Chile, Colombia and more | 4 | Terminated | Viatris | May 2015 | 180 |
| NCT01808300Healthy | 1 | Completed | Unimed Pharmaceuticals | Jul 2013 | 42 |
| NCT01770964Diabetes Mellitus · United States | 4 | UNKNOWN | Analgesic Solutions | Jul 2013 | 90 |
| NCT01747915Seizures · United States, Austria, Belarus and more | 3 | Completed | Viatris | Feb 20, 2019 | 219 |
| NCT01727791Breast Feeding · Belgium | 4 | Completed | Viatris | Aug 2013 | 10 |
| NCT01701362Neuralgia · United States, Bulgaria, Canada and more | 3 | Completed | Viatris | Aug 2015 | 542 |
| NCT01638273Healthy · Korea, Republic of | 1 | Completed | GL Pharm Tech | Jul 2014 | 24 |
| NCT01635751Healthy · Korea, Republic of | 1 | Completed | GL Pharm Tech | Nov 2012 | 30 |
| NCT01603394Neuralgia, Postherpetic · United States, Austria, Germany and more | 4 | Terminated | Pfizer | Jun 2013 | 9 |
| NCT01474772Diabetic Peripheral Neuropathy · United States, Czechia, South Africa and more | 3 | Completed | Viatris | Jul 2013 | 217 |
| NCT01463306Epilepsy · United States, Belarus, Belgium and more | 3 | Completed | Viatris | Aug 22, 2019 | 605 |
| NCT01455428Neuralgia, Postherpetic · China | 4 | Completed | Viatris | Jan 2014 | 223 |
| NCT01455415Painful Diabetic Peripheral Neuropathy · United States, Czechia, Italy and more | 3 | Completed | Viatris | Nov 2013 | 306 |
| NCT01432236Fibromyalgia · United States, Canada, Italy and more | 3 | Completed | Viatris | Jul 2013 | 197 |
| NCT01420913Healthy · Korea, Republic of | 1 | Completed | Yuhan | Aug 2011 | 28 |
| NCT01387607Fibromyalgia · China | 3 | Completed | Viatris | Oct 31, 2016 | 343 |
| NCT01332149Diabetic Neuropathies · China | 3 | Completed | Viatris | Apr 2014 | 626 |
| NCT01298466Low Back Pain | 4 | Withdrawn | Viatris | Feb 2013 | 0 |
| NCT01271933Fibromyalgia · United States, Canada, India and more | 3 | Completed | Viatris | Jul 2012 | 441 |
| NCT01270828Neuralgia, Postherpetic · United States, Bulgaria, Colombia and more | 3 | Completed | Viatris | Sep 2014 | 806 |
| NCT01262677Seizures · United States, Argentina, Bosnia and Herzegovina and more | 3 | Completed | Viatris | Jul 31, 2012 | 325 |
| NCT01257516Healthy · Belgium | 1 | Completed | Viatris | Mar 2011 | 18 |
| NCT01220219Healthy · Belgium | 1 | Completed | Viatris | Jan 2011 | 24 |
| NCT01202435Healthy · Belgium | 1 | Completed | Viatris | Nov 2010 | 18 |
| NCT01202422Healthy · Belgium | 1 | Completed | Viatris | Nov 2010 | 24 |
| NCT01202227Spinal Cord Diseases · Japan | 3 | Completed | Viatris | Mar 2012 | 104 |
| NCT01145417Neuralgia · United States, Colombia, India and more | 3 | Terminated | Viatris | May 2012 | 217 |
| NCT01117766Neuralgia · Austria, Belgium, France and more | – | Completed | Pfizer | Sep 2009 | 31 |
| NCT01080612Healthy · United States | 1 | Completed | Viatris | Jun 2010 | 24 |
| NCT01061372Restless Legs Syndrome | 3 | Withdrawn | Viatris | Aug 2011 | 0 |
| NCT01057693Diabetic Neuropathies · United States, Canada, Puerto Rico and more | 3 | Completed | Viatris | Jan 30, 2012 | 633 |
| NCT01049217Pain · United States, Colombia, Dominican Republic and more | 3 | Terminated | Viatris | May 2012 | 377 |
| NCT01020526Fibromyalgia · United States, Czechia, India | 4 | Completed | Viatris | Jun 2015 | 63 |
How it is read
Names in the registry
- “Pregabalin”, 80 entries
- “pregabalin”, 43 entries
- “pregabalin (Lyrica)”, 7 entries
- “Pregabalin ER”, 6 entries
- “Pregabalin 150mg”, 5 entries
Codes read as this program: YHD1119.
Conditions, from the studies’ own filings
- Neuralgia, 18 studies
- Fibromyalgia, 16 studies
- Diabetic Neuropathies, 14 studies
- Epilepsies, Partial, 12 studies
- Neuralgia, Postherpetic, 10 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.